Serif Biomedicines has emerged from stealth mode to continue developing “modified DNA,” a new class of therapeutics designed ...
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9–Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results